I bought CALA as it continues to consolidate after a 300% 1 week power move. The fact that this has bounced off the 10MA suggest that this could still be in play
Dynamic daily:
Theme: drug that shrinks breast cancer tumors. Management previously ran a private biotech that had a cancer treatment. That company was sold for over 700Million. That suggests there is a high level of competence.
Float: 17 Mill.
Market cap. 386 Mill.
EMES:
I've been waiting for this to trade up to the 10 Week average. It did today and was rejected. Given how well that has tracked this stock, I feel that it presents a low risk entry to the short side.
I bought the Feb 48 puts. for 1.38
Entry: $22.75
No comments:
Post a Comment